Рет қаралды 131,167
In this episode, Dr. Shawn Tassone discusses a recent study published in the Journal of the North American Menopause Society that challenges the previous negative views on hormone replacement therapy (HRT) for women over the age of 65. The study found that HRT, specifically estrogen therapy, beyond the age of 65 is associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia. The study also highlighted the importance of individualized hormone therapy, lower doses, and non-oral routes of administration for optimal health outcomes.
THESE THOUGHTS ARE MY OPINION AND DO NOT CONSTITUTE MEDICAL ADVICE